T. Rowe Price Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123K | Buy |
|
|||||
|
2025
Q1 | $252K | Buy |
|
|||||
|
2024
Q4 | $425K | Sell |
|
|||||
|
2024
Q3 | $426K | Buy |
|
|||||
|
2024
Q2 | $662K | Buy |
|
|||||
|
2024
Q1 | $746K | Buy |
|
|||||
|
2023
Q4 | $922K | Buy |
|
|||||
|
2023
Q3 | $695K | Buy |
|
|||||
|
2023
Q2 | $653K | Buy |
|
|||||
|
2023
Q1 | $630K | Sell |
|
|||||
|
2022
Q4 | $1.15M | Sell |
|
|||||
|
2022
Q3 | $1.04M | Buy |
|
|||||
|
2022
Q2 | $1.05M | Sell |
|
|||||
|
2022
Q1 | $1.15M | Sell |
|
|||||
|
2021
Q4 | $1.14M | Sell |
|
|||||
|
2021
Q3 | $1.59M | Sell |
|
|||||
|
2021
Q2 | $1.71M | Sell |
|
|||||
|
2021
Q1 | $1.69M | Sell |
|
|||||
|
2020
Q4 | $1.97M | Sell |
|
|||||
|
2020
Q3 | $8.64M | Sell |
|
|||||
|
2020
Q2 | $10.6M | Sell |
|
|||||
|
2020
Q1 | $12.4M | Buy |
|
|||||
|
2019
Q4 | $15.5M | Sell |
|
|||||
|
2019
Q3 | $10.1M | Buy |
|
|||||
|
2019
Q2 | $12.6M | Sell |
|
|||||
|
2019
Q1 | $29.8M | Sell |
|
|||||
|
2018
Q4 | $32M | Sell |
|
|||||
|
2018
Q3 | $165M | Sell |
|
|||||
|
2018
Q2 | $214M | Sell |
|
|||||
|
2018
Q1 | $188M | Sell |
|
|||||
|
2017
Q4 | $268M | Buy |
|
|||||
|
2017
Q3 | $267M | Buy |
|
|||||
|
2017
Q2 | $310M | Buy |
|
|||||
|
2017
Q1 | $278M | Buy |
|
|||||
|
2016
Q4 | $222M | Buy |
|
|||||
|
2016
Q3 | $139M | Buy |
|
|||||
|
2016
Q2 | $98.1M | Buy |
|
|||||
|
2016
Q1 | $73.4M | Buy |
|
|||||
|
2015
Q4 | $59.3M | Sell |
|
|||||
|
2015
Q3 | $53.4M | Sell |
|
|||||
|
2015
Q2 | $62.6M | Buy |
|
|||||
|
2015
Q1 | $42.1M | Buy |
|
|||||
|
2014
Q4 | $14.9M | Sell |
|
|||||
|
2014
Q3 | $18.4M | Sell |
|
|||||
|
2014
Q2 | $22.2M | Sell |
|
|||||
|
2014
Q1 | $22.8M | Sell |
|
|||||
|
2013
Q4 | $22.9M | Buy |
|
|||||
|
2013
Q3 | $20.2M | Buy |
|
|||||
|
2013
Q2 | $16M | Buy |
|